Rosiglitazone: a European regulatory perspective E. BlindK. DunderE. Abadie Commentary 14 December 2010 Pages: 213 - 218
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser Y. M. ChoT. J. Kieffer Commentary 30 November 2010 Pages: 219 - 222
The stress of starvation: glucocorticoid restraint of beta cell development L. C. MatthewsN. A. Hanley Commentary Open access 12 November 2010 Pages: 223 - 226
Gestational diabetes: costs and consequences R. S. Lindsay Commentary 26 November 2010 Pages: 227 - 229
Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient? H. C. Gerstein Commentary 20 November 2010 Pages: 230 - 232
Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited B. M. Frier Commentary 26 November 2010 Pages: 233 - 236
Targeting energy expenditure via fuel switching and beyond J. G. Geisler For Debate 17 October 2010 Pages: 237 - 244
Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort A. M. JacobsonC. M. Ryanand the DCCT/EDIC Research Group Article 29 August 2010 Pages: 245 - 255
Screening for gestational diabetes mellitus: cost–utility of different screening strategies based on a woman’s individual risk of disease J. A. RoundP. JacklinR. I. G. Holt Article 31 August 2010 Pages: 256 - 263
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes S. van DierenL. M. PeelenJ. W. J. Beulens Article Open access 14 November 2010 Pages: 264 - 270
The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes D. J. A. JenkinsK. SrichaikulL. A. Leiter Article Open access 27 October 2010 Pages: 271 - 279
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study T. M. E. DavisR. Tingon behalf of the FIELD Study investigators Article 04 November 2010 Pages: 280 - 290
Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk P. ChamnanR. K. SimmonsS. J. Griffin Article 23 September 2010 Pages: 291 - 299
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study Q. GongE. W. GreggP. H. Bennett Article 03 November 2010 Pages: 300 - 307
Immortal time bias and survival in patients who self-monitor blood glucose in the Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (ROSSO) F. HoffmannF. Andersohn Short Communication 19 September 2010 Pages: 308 - 311
Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort R. K. SimmonsM. RahmanS. J. Griffin Article 27 October 2010 Pages: 312 - 319
Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function R. C. Loopstra-MastersA. D. LieseA. J. Hanley Article 03 November 2010 Pages: 320 - 328
Lipoprotein-associated phospholipase A2 and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study T. L. NelsonA. KamineniK. J. Mukamal Short Communication 20 November 2010 Pages: 329 - 333
Association analysis of Notch pathway signalling genes in diabetic nephropathy D. KavanaghG. J. McKaythe Warren 3/UK GoKinD Study Group Short Communication 20 November 2010 Pages: 334 - 338
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice A. MaidaB. J. LamontD. J. Drucker Article 23 October 2010 Pages: 339 - 349
Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice B. ValtatC. DupuisB. Blondeau Article 21 September 2010 Pages: 350 - 359
Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA1c levels in human pancreatic islets B. T. YangT. A. DayehC. Ling Article Open access 23 November 2010 Pages: 360 - 367
Translationally controlled tumour protein (TCTP) is a novel glucose-regulated protein that is important for survival of pancreatic beta cells F. DiraisonK. HaywardA. Varadi Article 10 November 2010 Pages: 368 - 379
Deletion of protein kinase Cδ in mice modulates stability of inflammatory genes and protects against cytokine-stimulated beta cell death in vitro and in vivo J. CantleyE. BoslemT. J. Biden Article 20 November 2010 Pages: 380 - 389
Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells B. RogerJ. PapinJ. Lang Article 03 November 2010 Pages: 390 - 402
Alx3-deficient mice exhibit decreased insulin in beta cells, altered glucose homeostasis and increased apoptosis in pancreatic islets M. MirasierraA. Fernández-PérezM. Vallejo Article 21 November 2010 Pages: 403 - 414
Delayed onset of hyperglycaemia in a mouse model with impaired glucagon secretion demonstrates that dysregulated glucagon secretion promotes hyperglycaemia and type 2 diabetes N. GustavssonT. SeahW. Han Article 27 October 2010 Pages: 415 - 422
BK channels affect glucose homeostasis and cell viability of murine pancreatic beta cells M. DüferY. NeyeG. Drews Article 28 October 2010 Pages: 423 - 432
Beta cell function during rapamycin monotherapy in long-term type 1 diabetes L. PiemontiP. MaffiE. Bonifacio Article 03 November 2010 Pages: 433 - 439
Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes Y. WangY. NakagawaY. Liu Article 04 November 2010 Pages: 440 - 450
Comparison of two sulfonylureas with high and low myocardial KATP channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes S. B. KristiansenB. LøfgrenH. E. Bøtker Article 21 November 2010 Pages: 451 - 458
The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy T. ZhouK. K. ZhouJ-x. Ma Article Open access 27 October 2010 Pages: 459 - 468
Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation N. Zwaveling-SoonawalaE. E. HagebeukA. S. van Trotsenburg Research Letter Open access 26 November 2010 Pages: 469 - 471
Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance? A. C. ManolakisE. K. TiakaS. P. Potamianos Research Letter 30 November 2010 Pages: 472 - 474
Immortal time bias does not invalidate the association of self-monitoring of blood glucose with better survival of patients with type 2 diabetes in the epidemiological study ROSSO (Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes) B. SchneiderS. MartinH. Kolb Letter 20 November 2010 Pages: 475 - 476